The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global endoscopy devices market reached a value of US$ 37 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 6.3% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Endoscopy devices are long and thin tubes inserted inside the body via mouth or incision to examine the interior of ears, nose, bladder, esophagus, stomach, colon, throat, heart, urinary tract, joints, and abdomen. These tubes have a camera and light source attached, which help healthcare professionals to perform biopsies and laparoscopic and arthroscopy surgeries. At present, they are available in different lengths and flexibilities depending on diagnostic organs. For instance, rigid tubular endoscopes are utilized by doctors to examine joints, while flexible fiber-optic devices are used for assessing the colon.
A considerable rise in the prevalence of cancer and gastrointestinal disorders represents one of the primary factors driving the endoscopy devices market. Additionally, endoscopy devices can be used to investigate unusual symptoms like dysphagia, diarrhea, weight loss, heartburn, and stool blood. Consequently, the growing pediatric population, which is relatively more vulnerable to targeted diseases, is further influencing the utilization of flexible endoscopes for diagnosis and treatment. Apart from this, the leading players are introducing capsule or robot-assisted endoscopy devices with ultra-high-definition (UHD) visualization systems. These players are also offering easy-to-handle light sources and state-of-the-art video equipment to support the use of endoscopy devices in microsurgical techniques, which is contributing to the market growth. Furthermore, the growing adoption of modern endoscopy devices that incorporate distal lens designs to provide a wider field of view, in confluence with the increasing consumer preferences for minimal post-surgical complications, is anticipated to foster the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global endoscopy devices market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on type, application and end use.
Breakup by Type:
Breakup by Application:
Breakup by End Use:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, Johnson & Johnson, FUJIFILM Holdings Corporation, HOYA Corporation, Karl Storz SE & Co. KG, Machida Endoscope Co. Ltd, Medtronic Plc, Olympus Corporation, Richard Wolf GmbH, Smith & Nephew plc and Stryker Corporation.
|Base Year of the Analysis||2020|
|Segment Coverage||Type, Application, End Use, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Boston Scientific Corporation, Johnson & Johnson, FUJIFILM Holdings Corporation, HOYA Corporation, Karl Storz SE & Co. KG, Machida Endoscope Co. Ltd, Medtronic Plc, Olympus Corporation, Richard Wolf GmbH, Smith & Nephew plc and Stryker Corporation|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at